Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

No injuries were reported. The cause of the fire is still under investigation. Fire departments from surrounding localities ...

Phlow, a South Carolina-based medicine supply chain company, reeled in $36 million in series B fundraising to help the company expand its contract manufacturing program. The company has earmarked ...

Phlow’s expanded laboratory space now offers comprehensive analytical services, including industry-leading analytical solutions for drug assays, impurity characterization and control, purity ...

RICHMOND, Va., May 19, 2020 /PRNewswire/ -- Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing ...

“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.